Savara (SVRA) Non-Current Assets (2010 - 2026)

Savara's (SVRA) quarterly Non-Current Assets came in at $12.4 million in Q1 2026, up 4.28% year-on-year from $11.9 million in Q1 2025, and up 4.74% on a QoQ basis from $11.8 million in Q4 2025.

Savara (SVRA) Non-Current Assets (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Non-Current Assets data on file, last reported at $12.4 million in Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 4.28% year-over-year to $12.4 million in Q1 2026; TTM through Mar 2026 was $49.7 million, a 5.72% increase from a year earlier, with the FY2025 full-year figure at $11.8 million, up 10.01% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $12.4 million, up from $11.8 million in the prior quarter.
  • Over the last five years, Non-Current Assets for SVRA reached as high as $12.8 million in Q2 2025 and fell as low as $10.7 million in Q3 2022.
  • Historically, Non-Current Assets has averaged $11.8 million across 5 years, with a median of $11.9 million in 2025.
  • Across the five-year window, Non-Current Assets declined 15.77% in 2022 and grew 12.04% in 2023, its largest moves.
  • Year by year, Non-Current Assets stood at $10.8 million in 2022, then increased by 7.34% to $11.6 million in 2023, then slipped by 7.51% to $10.7 million in 2024, then advanced by 10.01% to $11.8 million in 2025, then advanced by 4.74% to $12.4 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $12.4 million in Q1 2026, $11.8 million in Q4 2025, and $12.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Savara 1.24 Bn 1.24 Bn - 12.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.38 Mn
Dec 31, 2025 11.82 Mn
Sep 30, 2025 12.73 Mn
Jun 30, 2025 12.78 Mn
Mar 31, 2025 11.87 Mn
Dec 31, 2024 10.74 Mn
Sep 30, 2024 12.42 Mn
Jun 30, 2024 11.98 Mn
Mar 31, 2024 12.11 Mn
Dec 31, 2023 11.62 Mn
Sep 30, 2023 11.98 Mn
Jun 30, 2023 11.93 Mn
Mar 31, 2023 11.73 Mn
Dec 31, 2022 10.82 Mn
Sep 30, 2022 10.69 Mn
Jun 30, 2022 11.39 Mn
Mar 31, 2022 11.67 Mn
Dec 31, 2021 11.60 Mn
Sep 30, 2021 12.69 Mn
Jun 30, 2021 12.95 Mn